These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Anti-AT1R autoantibodies and prediction of the severity of Covid-19. Papola F; Biancofiore V; Angeletti C; Grimaldi A; Carucci AC; Cofini V; Necozione S; Rosciano A; Marinangeli F; Cervelli C Hum Immunol; 2022 Feb; 83(2):130-133. PubMed ID: 34772541 [TBL] [Abstract][Full Text] [Related]
12. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Richter AG; Shields AM; Karim A; Birch D; Faustini SE; Steadman L; Ward K; Plant T; Reynolds G; Veenith T; Cunningham AF; Drayson MT; Wraith DC Clin Exp Immunol; 2021 Aug; 205(2):99-105. PubMed ID: 34082475 [TBL] [Abstract][Full Text] [Related]
13. Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases. Cabral-Marques O; Riemekasten G Nat Rev Rheumatol; 2017 Nov; 13(11):648-656. PubMed ID: 28855694 [TBL] [Abstract][Full Text] [Related]
14. Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes. Moody R; Sonda S; Johnston FH; Smith KJ; Stephens N; McPherson M; Flanagan KL; Plebanski M Front Immunol; 2022; 13():945021. PubMed ID: 36032086 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren's syndrome. Yue X; Deng F; Chen J; Yin J; Zheng J; Chen Y; Huang Q; Gao X; Liu Z; Luo J; Müller A; Heidecke H; Riemekasten G; Petersen F; Yu X Mol Immunol; 2021 Mar; 131():112-120. PubMed ID: 33446393 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3. Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G Front Immunol; 2018; 9():428. PubMed ID: 29623076 [TBL] [Abstract][Full Text] [Related]
17. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Chang SE; Feng A; Meng W; Apostolidis SA; Mack E; Artandi M; Barman L; Bennett K; Chakraborty S; Chang I; Cheung P; Chinthrajah S; Dhingra S; Do E; Finck A; Gaano A; Geßner R; Giannini HM; Gonzalez J; Greib S; Gündisch M; Hsu AR; Kuo A; Manohar M; Mao R; Neeli I; Neubauer A; Oniyide O; Powell AE; Puri R; Renz H; Schapiro J; Weidenbacher PA; Wittman R; Ahuja N; Chung HR; Jagannathan P; James JA; Kim PS; Meyer NJ; Nadeau KC; Radic M; Robinson WH; Singh U; Wang TT; Wherry EJ; Skevaki C; Luning Prak ET; Utz PJ Nat Commun; 2021 Sep; 12(1):5417. PubMed ID: 34521836 [TBL] [Abstract][Full Text] [Related]
18. IgG autoantibodies against ACE2 in SARS-CoV-2 infected patients. Hallmann E; Sikora D; Poniedziałek B; Szymański K; Kondratiuk K; Żurawski J; Brydak L; Rzymski P J Med Virol; 2023 Jan; 95(1):e28273. PubMed ID: 36324055 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19. Gomes C; Zuniga M; Crotty KA; Qian K; Tovar NC; Lin LH; Argyropoulos KV; Clancy R; Izmirly P; Buyon J; Lee DC; Yasnot-Acosta MF; Li H; Cotzia P; Rodriguez A Life Sci Alliance; 2021 Nov; 4(11):. PubMed ID: 34504035 [TBL] [Abstract][Full Text] [Related]